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Abstract 
 
The present study was aimed to evaluate the efficacy of kokilaksha ksheeravasti in 
rheumatoid arthritis w.r.t.vatashonita. Rheumatoid Arthritis has great similarities to 
vatasonitam in Ayurveda. In the treatment principle of Vatashonita, shodhana therapy has 
been given prime importance. 15 patients fulfilling the criteria for the diagnosis of the disease 
were registered for the present study according to inclusion criteria. Initially Deepana, 
Pachana, Rookshana was done followed  by administration of kokilaksha ksheeravasti for 7 
days. Follow up period was of 15 days in which guggultiktakam ghritam was given. 
Assessment was done at clinical level and investigation level after the treatment and after 
follow up period. After Statistical analysis it can be concluded that kokilaksha ksheeravasti 
was effective in reducing the clinical signs and symptoms of Rheumatoid Arthritis. 
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Introduction 
Changing lifestyle, fast life, 
industrialization, changing food habits, 
stress and competition makes up a colony 
in which the man of present era is 
surviving. These factors have played an 
essential role to prick the mental and 
physical well being of a person, which in 
turn also reflects on social and spiritual 
well being. This has endangered the life of 
the person by giving rise to many dreadful 
diseases. One of such disease is 
Rheumatoid arthritis, which is a chronic, 
destructive, inflammatory disease which 
can make a man to cripple unless timely 
interventions are done. The prevalence of 
Rheumatoid Arthritis is approximately 
0.8% of the population (range – 0.3 to 
2.1%), women are affected 3 times more 
often than men.(1)  
The Rheumatoid arthritis has 
created universal interest among the 
research scholars, all over the world. 
Inspite of lots of work done on these 
aspects, a complete cure of disease is still 
awaited. Many studies have been 
conducted on rheumatoid arthritis .Some 
scholars have conducted studies 
considering it as vatashonita while some 
as amavata; thereby trying to provide 
effective, safe and less complicated 
treatment. 
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Rheumatoid arthritis is considered 
under the broad spectrum of vatashonita. 
There are similarities in the signs and 
symptoms of Rheumatoid arthritis and 
Vatashonita. Agnimandya is major cause 
of rakta(blood) vitiation whereas the 
avarna(covering) to vata by rakta is cause 
of vata vitiation. Thus the vitiated vata and 
rakta plays a major role in the 
pathogenesis of Vatashonita.(2)The line of 
treatment of Rheumatoid arthritis can be 
considered as that of Vatashonita. The 
treatment is aimed to remove the avarana 
of rakta, strotoshodhana and 
vatanulomana. In ayurvedic literature 
numbers of herbal preparations and also 
various panchakarma procedures are 
indicated in Vatashonita .Ksheeravasti has 
been given prime importance in 
Vatashonita.(3) Here, a clinical study to 
evaluate the efficacy of kokilaksha 
Ksheersvasti in Rheumatoid arthritis has 
been designed. 
 
Aim and Objectives 
 To study the efficacy of Kokilaksha 
Ksheeravasti in the management of 
Rheumatoid Arthritis. 
 
Materials & Methods: 
Source of Data and Method of 
Collection 
15 patients fulfilling the criteria for 
the diagnosis of the disease were 
registered for the present study according 
to inclusion criteria. The Patients were 
selected from the O.P.D & I.P.D of 
department of Panchakarma, Govt. 
Ayurveda College, Thiruvananthapuram. 
Necessary investigations were carried out 
and their details were recorded in the 
special proforma. 
 
Inclusion Criteria 
 According to the revised criteria for 
classification of Rheumatoid Arthritis 
by American College of 
Rheumatology. 
 Age group 30 – 60 years 
 Sex: Female and Male 
 Patient fit for Vasti 
 Patient with written informed consent 
 
Exclusion Criteria 
 Patients having other arthritis 
disorders. 
 Rheumatoid arthritis with gross 
deformity and complications. 
 Those who have under gone surgical 
treatment in the affected joints. 
 Pregnant Females. 
 Juvenile arthritis. 
 Patients with severe systemic diseases. 
 
Investigations 
  They were investigated in the 
laboratory of Govt. Ayurveda Hospital, 
Thiruvananthapuram for routine 
Hematological test (Hb %, TLC, DLC, 
ESR, LFT, RFT, Lipid profile, RA factor). 
 
Treatment Schedule  
Initially deepana, pachana drugs 
were administered to correct the amatwa 
seen in the patients. The amalakshanas 
included agni mandya, aruchi, klama etc. 
For this shaddharana choorna and 
Amruthotara kashaya was advised to be 
taken twice daily. Those in whom joints 
swelling were present lepana and 
dhanyamala dhara were applied according 
to avastha. When samyaka langhana 
lakshana were seen, administration of 
sodhana procedure was done. Necessary 
assessments were done before treatment, 
after treatment, and after follow up of 15 
days. Administration of kokilaksha 
ksheeravasti for 7 consecutive days was 
done. 
 
Materials 
 Kokilaksha ksheerapaka - 200ml 
 Guggulutiktakam Gritham  - 100ml 
 Madhuyastyadi Tailam - 100ml 
 Madhu - 100ml 
 Saindhava - 5gms 
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Preparation of kokilaksha Ksheeravasti 
Initally madhu and saindhava were 
added to the mortar and well ground with 
the pestle. After mixing them together, 
Madhuyastyadhi Taila was added in thin 
stream with continued grinding. It was 
followed by thin stream of liquified 
Guggulutiktaka Gritha. After a uniform 
mixture is obtained, Kokilaksha 
ksheerapaka was added in a thin stream 
while continuing the grinding. After all the 
contents were mixed to form a uniform 
mixture, it was filtered through a clean 
cloth and made luke warm with boiling 
watervapour. Then this mixture is churned 
with help of churner for a few minutes. 
The mixture obtained was uniformly 
mixed and done lukewarm. This was put in 
a clean and sterile thick plastic cover 
(Vasti Putaka) and Vasti netra made of 
plastic was tied to it, after plugging with 
cotton. 
 
Administration of kokilaksha 
Ksheeravasti 
Poorvakarma –  
Patient was asked to be  empty 
stomach after their daily routine till vasti 
was introduced. At 10.30am they were 
given abhyanga with pinda tailam and 
Bashpaswedam. Their blood pressure and 
pulse rate were recorded. 
 
Pradhankarma –  
Patient was asked to lie in the left 
lateral position, for introduction of 
kokilaksha Ksheeravasti. 
 
Paschatkarma –  
Patient was asked to lie in the 
supine position till the urge of defecation 
occurs. They were asked to clear the 
bowels and take bath with hot water. The 
light food like rice was given with 
Mudgayush. Blood pressure, pulse rate, 
time of retention, number of evacuations 
and discomfort were observed. They were 
asked to take rest then and light food was 
given at night.  
Post Vasti regime 
After kokilaksha Ksheeravasti, 
patient was discharged and advised to 
follow pariharakala. They were told to 
avoid excess sitting, standing, speaking, 
travelling, day sleep, coitus, vegadharana, 
exposure to cold or sunrays, sorrow, anger, 
irregular and unwholesome diet for a 
period of 15 days. During followup period 
they were advised to take Guggulutiktaka 
Gritha 15ml twice a day after food. 
 
Duration of Study 
The study was carried out within 
18 months. 
 
Assessment of Response to Treatment 
Both subjective and objective 
parameters were considered for assessing 
the response. To evaluate the changes in 
blood, laboratory findings were also 
included. 
 
Clinical Assessment 
The following parameters were 
used for assessment of clinical response. 
 
1. Pain:  
The visual analogue scale was 
adopted in the study. 
 
2. Morning Stiffness 
Mild - < 1 hr 
Moderate - 1-2 hrs 
Severe  - 2-3 hrs 
Very severe - > 3 hrs 
3. Tenderness 
Grade I - Patient complaints of 
pain. 
Grade II - Patient winces with 
pain 
Grade III - Patient winces and 
withdraws the affected 
parts   
Grade IV       - Patient will not allow 
the joint to be touched. 
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4. Joint Count:  
 Number of the inflamed joints 
represents the joint count. 
 
5. Joint Circumference:  
 Joint circumference of individual 
pairs of joints was assessed using a Simple 
measuring tape for the joint swelling. 
 
6. Hand grip strength:   
This was recorded using 
Sphygmomanometer. The de-inflated cuff 
of the instrument was rolled and inflated 
while the patient holds it with one hand.  
The height to which the mercury column 
raised when the patient just looses the grip 
was recorded.  For avoiding inaccuracy in 
measurement, the mean of three 
measurements was taken. 
 
7. Joint mobility 
Grade I - Normal mobility 
GradeII - Slight restriction, can 
manage 
publicTransport. 
Grade III  - Can cross roads, cannot 
manage public 
transport. 
Grade IV  
- 
Can use stairs, can go 
out, but cannot cross 
roads 
Grade V - Cannot use stairs. 
Grade VI - Can move from room to 
room with help. 
Grade VII - Confined to chair or 
bed. 
 
8. Functional assessment  
Grade   I - Can perform all 
activities 
Grade II - Moderate restriction of 
activities performed 
with difficulty due to 
pain or limitation of 
movement. 
Grade III - Marked restriction of 
activities 
Grade IV - Incapacitated or 
confined to bed or 
chair. 
 
9. Discoloration of skin 
Discoloration present 
before treatment  
- 2(score) 
Discoloration reduction 
after treatment 
- 1(score) 
No discoloration - 0(score) 
No change in 
discoloration after 
treatment 
- 2(score) 
 
Lab parameters used for assessment 
 Hemoglobin percentage 
 ESR 
 RA Factor (dilution) 
 
Criteria for Assessing the Total Effect: 
Considering the overall 
improvement in signs and symptoms 
shown by the patients, the total effect of 
the therapy had been assessed as below – 
 Cured : 100% subsidence of 
presenting complaint 
 Major improvement : More than 
50% relief in the complaints of the 
patient 
 Moderate improvement :25 – 50% 
relief in the complaints of the 
patient 
 Mild improvement :Up to 25% 
relief in the complaints of the 
patient  
 
Statistical Analysis: 
 The efficacy of treatments was 
analyzed by calculating the mean, standard 
deviation of the parameters; t & p values 
were found using paired‘t’test.  
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Observation and Results 
Table no.1 Data related to response to the treatment 
Variables Stage  Mean  SD N  Mean 
difference 
Paired t p value %Relief 
Pain BT 9.07 0.80 15     
AT 5.27 1.16 15 3.80 26.252 <.001 26.5 
AFU 2.00 0.76 15 7.07 106 <.001 58.97 
Tenderness BT 2.53 0.52 15     
AT 1.07 0.26 15 1.47 11.00 <.001 58.1 
AFU 0.93 0.26 15 1.60 12.220 <.001 63.24 
Morning 
Stiffness 
BT 3.47 0.52 15     
AT 2.33 0.49 15 1.13 12.474 <.001 32.56 
AFU 1.40 0.51 15 2.07 31.00 <.001 59.65 
Joint Mobility BT 4.20 0.41 15     
AT 2.13 0.35 15 2.07 31.00 <.001 49.28 
AFU 1.13 0.35 15 3.07 40.00 <.001 73.09 
Joint Count BT 20.53 1.60 15     
AT 13.47 2.33 15 7.07 21.384 <.001 34.43 
AFU 13.47 2.33 15 7.077 21.384 <.001 34.43 
Functional 
Capacity 
BT 2.63 0.49 15     
AT 1.53 0.52 15 1.13 12.47 <.001 42.96 
AFU 1.20 0.41 15 1.47 11.00 <.001 55.89 
Grip Strength BT 1.67 0.49 15     
AT 3.60 0.51 15 1.93 29.00 <.001 86.52 
AFU 3.60 0.51 15 1.93 29.00 <.001 86.52 
Joint Swelling BT 1.60 0.51 15     
AT 1.07 0.26 15 0.53 4.00 <.001 33.12 
AFU 1.07 0.26 15 0.53 4.00 <.001 33.12 
Discoloration 
of skin 
BT 2.00  10     
AT 1.20 0.42 10 0.80 6.00 <0.001 40 
AFU 1.20 0.42 10 0.80 6.00 <0.001 40 
Hb% BT 10.34 0.51 15     
AT 10.54 1.15 15 0.20 5.916 <.001 1.9 
AFU 10.76 1.11 15 0.41 6.54 <.001 4.06 
ESR BT 4.13 0.64 15     
AT 2.20 0.41 15 1.93 16.358 <.001 46.93 
AFU 2.07 0.46 15 2.07 11.370 <.001 50.12 
RA BT 1.00  11     
AT 0.73 0.47 11 0.27 1.936 >0.05  
AFU 0.73 0.47 11 0.27 1.936 >0.05  
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Table No.2 Overall Effect of the Therapy 
 
Discussion: 
 RA is one of the most debilitating 
disorders which affect the significant 
portion of the middle aged population 
dominated by the females all over the 
world. Its treatment is still a big question 
to the current mainstream medical science, 
making the patient dependent and 
bedridden gradually .The present study is 
aimed to evaluate the efficacy of the 
kokilaksha ksheeravasti in Rheumatoid 
arthritis. 
The both Ayurvedic and modern 
texts and other publications, internet and 
other related research were referred for the 
same .Initially deepana, pachana and 
rookshana was done for correcting the 
agni, then followed by administration of 
kokilaksha ksheeravasti for 7 days. 
Kokilaksha is vata pitha samana drug and 
has been given prime importance in 
vatasonita(4) .Ksheeravasti is mrudu 
nirooha designed particularly for the 
durbala, snigdha in property. It also 
provides samana action with appropriate 
vyadhihara drugs. Then patient was 
discharged and the follow up period was of 
15 days in which they  were advised to 
take guggulutiktaka ghrita  15ml after 
food twice daily. The remnants of the 
doshas in smaller quantites following 
shodhana should be treated with samana 
oushadhies, so the patients were given 
guggulutiktaka ghrita for period of 15 
days. The particular drug was selected 
considering the gambheera avastha of the 
disease and its special indication for 
vatashonita(5). The patients were advised 
to maintain the contact as well as to note 
the changes that occurred. 
It was observed from the data 
collected as a part of study, that majority 
of patients were females within the age 
group of 40-50 yrs .Most of the patients 
were doing household job and were having 
mixed food  habits which may be 
contributory to the disease. 
Maximum 60% of the patients 
were having 21 to 30 mins retention time 
followed by 31 to 40 mins in 20% patients, 
11 to 20 mins in 13.33% and up to 10 mins 
in   6.66% patients Amongst samyaka 
nirooha lakshanas  prasrushta vita, 
prasrushta mutra, prasrushta vata and 
roga upashanti were observed in all 
patients, followed by 80%  patients with 
ashaya laghavata . 
With regard to response to treatment  
 
After treatment  
Considerable improvement in all 
the parameters was noticed. Regarding 
hematological parameters considerable 
improvements were seen in Hb%, ESR 
was reduced but did not show any changes 
in RA factor. 
 Thus, it can be inferred that the 
kokilaksha ksheeravasti is effective in 
reducing signs and symptoms of the 
patients and also proved helpful in certain 
haematalogical parameter. 
 
After follow up 
All the parameters were highly 
significant .Considerable improvement in 
all the parameters were noticed. Regarding 
Overall effects  Ksheeravasti 
AT AFU 
No. % No. % 
Minor improvements 0 0 0 0 
Moderate improvements 15 100 3 20 
 Major improvements 0 0 12 80 
Complete cure 0 0 0 0 
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hematological parameters considerable 
improvements were seen in Hb% .ESR 
was reduced but did not show any changes 
in RA factor. 
Thus, it can be inferred that the 
kokilaksha ksheeravasti is effective in 
reducing signs and symptoms of the 
patients and also proved helpful in certain 
haematalogical parameter. 
Thus for overall effect of therapy, 
it can be said that with kokilaksha 
ksheeravasti 80% patients showed major 
improvements and 20% showed moderate 
improvement. 
 
Probable mode of action of Ksheeravasti 
In the present study kokilaksha 
ksheeravasti was found to be more 
effective in reducing signs and symptoms 
of the patients In the study, ksheeravasti 
consisted of kokilaksha ksheerapaka, 
guggulutiktaka ghrita, madhuyashtyadi 
taila, madhu and saindhava. Clinically 
mainly the joint involvement is seen in the 
patients and the prime vitiating factors are 
the vata and rakta. The treatment should 
serve the purpose of strotoshodhana and 
vatanulomana. So a nirooha yoga that 
fulfills all the purpose was selected  and 
modified accordingly, to correct asthi vaha 
strotas .Ksheera vasti is such an vatagna 
yoga that induces bala, snehana and when 
used with tikta ksheera and ghrita, it acts 
specifically on asthi dhatu. Its action is 
according to Arrunadatta’s commentary(6) 
-“Any dravya which is snigdha, shoshana 
and produces kharatva is suitable for 
asthikshaya because basic quality of 
asthidhatu is khara. There is not a single 
dravya in the universe which is snigdha 
and shoshana. Thikta is the rasa which is 
having most shoshana swabhava, it 
produces kharatva which is the pradhana 
guna of Asthidhatu. Thikta rasa when 
combined with ksheera or gritha will 
improve the dridatha of asthidhatu, 
resulting in asthiposhana and 
asthivardhana.The combination of tikta 
dravyas with ksheera and ghrita fulfills 
this purpose. Hence this vasthi being 
vatahara by nature, produces kharatva in 
the shareera, but does not cause 
vataprakopa because of snigdhatva of 
ksheera and gritha. Ksheera and gritha are 
the best dravyas in degenerative 
conditions. More over vasthi stays in 
pakwasaya, where pureesha dhara kala 
exists and does its action(7)
. 
Pureeshadhara and Asthidhara kalas are 
one and the same(8), kharatva produced in 
Thikta gritha ksheera vasthi, helps in 
normal formation of asthidhatu in 
shareera, thus improving the condition.  
 
Conclusion 
 Rheumatoid Arthritis is a type of 
polyarthritis with multisystem 
involvement caused by altered 
immune status. 
 It is similar to Vatashonita in many 
aspects, caused by Vatakopa and 
raktadushti manifesting primarily in 
the sandhis. 
 Ksheeravasti reduces the clinical signs 
and symptoms of RA. 
 Ksheeravasti reduces ESR and also 
improves Hb% of the patients. 
 Ksheeravasti enhances the general 
health status of the patients. 
 
Limitations: 
 Sample size was very small. 
 The period of study was limited. 
 Longer follow up was not done. 
 Immunological parameters other than 
RA factor were not studied. 
 
Recommendations: 
 Longer follow up should be done. 
 Effect on other immunological 
parameters other than RA factor 
should be studied. 
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 This study can be continued with 
repeated intervals of the treatment 
with large sample size. 
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